N'oge na-adịbeghị anya, Novo Nordisk wepụtara akụkọ gbasara ego ya na 2022. Data na-egosi na ọnụ ahịa Novo Nordisk na 2022 ga-eru 176.954 ijeri Danish krone (US $ 24.994 ijeri, mgbanwe mgbanwe ọnụego ekwuputara na akụkọ kwa afọ, otu n'okpuru), elu 26% afọ na afọ, uru uru ga-eru 74.809 ijeri Danish krone. (US $ 10.566), elu 28% afọ na afọ, na net uru ga-55.525 ijeri Danish krone (US $ 7.843 ijeri), elu 16% afọ na afọ. Arụmọrụ ahụ dị oke egwu.

Ebee ka arụmọrụ pụtara ìhè Novo Nordisk si bia? Azịza ya bụ GLP-1 analogue. N'ime pipeline ngwaahịa Novo Nordisk, enwere ike kewaa ngwaahịa n'ime ụdị anọ: GLP-1 analogues, insulin na analogues, coagulation factor na hormones metabolic ndị ọzọ, na ire nke 83.371 ijeri Danish krone ($ 11.176, ewezuga agịga ibu ibu), 52.952 ijeri Danish. krone ($ 7.479 ijeri), 11.706 ijeri Danish krone ($ 1.653 ijeri) na 7.138 ijeri Danish krone ($ 1.008 ijeri), n'otu n'otu. N'ime analogues GLP-1, ire nke ọgwụ mgbochi hypoglycemic Liraglutide na-ebelata kwa afọ, ebeSemaglutidebụ ihe na-adọrọ adọrọ nke ukwuu, yana ngụkọta ahịa nke ijeri dollar 10.882 na 2022.